Want to see HK:6990 full AI Analyst Report?

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990) Revenue

2 Followers

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H Revenue

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H had a revenue of 489.17M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 2.20B, Decreased 0.64%. In the fiscal year ending Dec 31, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H had annual revenue of 2.06B with 6.46% growth.

Revenue (ttm)

2.20B

Revenue Growth

43.88%

P/S Ratio

52.24

Revenue/Employee

HK$894,748

Employees

2,300

Market Cap

HK$107.51B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	2.06B	124.88M	+6.46%
Dec 31, 2024	1.93B	392.55M	+25.48%
Dec 31, 2023	1.54B	736.56M	+91.62%
Dec 31, 2022	803.93M	772.14M	+2,428.56%
Dec 31, 2021	31.79M	―	―